Pituitary carcinoma with malignant growth from first presentation and fulminant clinical course - Case report and review of the literature

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages 2665-2669

  Dudziak, Katarzyna ^a,b   Honegger, Jürgen ^a,b   Bornemann, Antje ^a,b   Horger, Marius ^a,b   Müssig, Karsten ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Kaiserswerther Diakonie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTISONE ACETATE; CYTARABINE; DESMOPRESSIN ACETATE; DEXAMETHASONE; ETIRACETAM; ETOPOSIDE; KI 67 ANTIGEN; METHOTREXATE; TESTOSTERONE; THYROXINE;

ADULT; AUTOPSY; BLOOD PRESSURE; CANCER INFILTRATION; CANCER RADIOTHERAPY; CASE REPORT; CEREBELLUM; CEREBROSPINAL FLUID CIRCULATION DISORDER; CONFERENCE PAPER; CONFUSION; DEATH; DISEASE COURSE; DIZZINESS; FATIGUE; FOLLOW UP; GENERAL CONDITION DETERIORATION; HEADACHE; HORMONE SUBSTITUTION; HOSPICE CARE; HUMAN; HUNGER; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; HYPOTHALAMUS; LIBIDO DISORDER; LUMBAR PUNCTURE; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NOCTURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; POLYDIPSIA; PRIORITY JOURNAL; SEIZURE; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT REFUSAL; TUMOR GROWTH; TUMOR RECURRENCE; VISUAL FIELD DEFECT; VISUAL SYSTEM; WHOLE BODY CT;

CARCINOMA; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 80052525186     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1166     Document Type: Conference Paper

References (11)

1. Asa S.L., Ezzat S. 2009 The pathogenesis of pituitary tumors. Annu Rev Pathol 4:97-126
2. Ezzat S., Asa S.L., Couldwell W.T., Barr C.E., Dodge W.E., Vance M.L., McCutcheon I.E. 2004 The prevalence of pituitary adenomas: A systematic review. Cancer 101:613-619 (Pubitemid 38970613)
3. Hall W.A., Luciano M.G., Doppman J.L., Patronas N.J., Oldfield E.H. 1994 Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population. Ann Intern Med 120:817-820 (Pubitemid 24140506)
4. Teramoto A., Hirakawa K., Sanno N., Osamura Y. 1994 Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193:161-164 (Pubitemid 24298018)
5. Saeger W., Lüdecke D.K., Buchfelder M., Fahlbusch R., Quabbe H.J., Petersenn S. 2007 Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203-216 (Pubitemid 46554515)
6. Lübke D., Saeger W. 1995 Carcinomas of the pituitary: Definition and review of the literature. Gen Diagn Pathol 141:81-92
7. Kars M., Roelfsema F., Romijn J.A., Pereira A.M. 2006 Malignant prolactinoma: Case report and review of the literature. Eur J Endocrinol 155:523-534 (Pubitemid 44636871)
8. Raverot G., Sturm N., De Fraipont F., Muller M., Salenave S., Caron P., Chabre O., Chanson P., Cortet-Rudelli C., Assaker R., Dufour H., Gaillard S., François P., Jouanneau E., Passagia J.G., Bernier M, Corné- lius A, Figarella-Branger D, Trouillas J, Borson-Chazot F, Brue T 2010 Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 95:4592-4599
9. Kaltsas G.A., Nomikos P., Kontogeorgos G., Buchfelder M., Grossman A.B. 2005 Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089-3099 (Pubitemid 40686369)
10. Vilar E., Salazar R., Pérez-García J., Cortes J., Oberg K., Tabernero J. 2007 Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer 14:221-232 (Pubitemid 47242624)
11. Gaffey T.A., Scheithauer B.W., Lloyd R.V., Burger P.C., Robbins P., Fereidooni F., Horvath E., Kovacs K., Kuroki T., Young W.F. Jr, Sebo T.J., Riehle D.L., Belzberg A.J. 2002 Corticotroph carcinoma of the pituitary: A clinicopathological study. Report of four cases. J Neurosurg 96:352-360 (Pubitemid 34230252)